Funding Opportunities

This is a listing of Requests for Applications (RFA), Program Announcements (PA), and Notices specific to the group's key programs.

Standard submission dates apply for all listings, unless otherwise noted.

Guidance For Investigators Planning to Submit a Program Project Grant (P01)

NCI SBIR Contract Solicitation Digital Tools to Integrate Cancer Prevention Within Primary Care (https://sbir.cancer.gov/small-business-funding/contracts/current-solicitation/453This solicitation will be open to applications through November 4th.

Notice: Internet links not permitted in NIH Grant Applications

Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Title Sort descending Announcement Number Activity Code Clinical Trials Status Expiration Date Program Official
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) PAR-22-114 Clinical Trial Optional 01/24/2025 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-23-003 (R33 Clinical Trial Not Allowed) R33 Clinical Trial Not Allowed 09/02/2023 Guillermo Marquez, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) UH2, UH3 Clinical Trial Not Allowed 10/11/2023 Lynn Sorbara, Ph.D.
Assay Validation of High Quality Markers for Clinical Studies in Cancer PAR-20-314 (UH3 Clinical Trials Not Allowed) UH3 10/11/2023 Lynn Sorbara, Ph.D.
Basic Research in Cancer Health Disparities PAR-21-323 (R21 Clinical Trial Not Allowed) R21 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-324 (R03 Clinical Trial Not Allowed) R03 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities PAR-21-322 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 09/08/2024 Asad Umar, D.V.M., Ph.D.
Biology of Bladder Cancer PAR-22-219 (R21 Clinical Trial Optional) R21 Clinical Trial Optional 09/08/2025 Chen Suen, Ph.D., R.Ph.
Biology of Bladder Cancer PAR-22-218 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 09/08/2025 Chen Suen, Ph.D., R.Ph.
Cancer Immunoprevention Network (CIP-Net) Research Projects RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed) UH3, UG3 07/04/2024 Altaf Mohammed, Ph.D.